Published in Psychiatry Res on November 28, 2006
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry (2009) 1.28
Components of emotion dysregulation in borderline personality disorder: a review. Curr Psychiatry Rep (2013) 1.10
The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry (2011) 1.04
Mechanisms of disturbed emotion processing and social interaction in borderline personality disorder: state of knowledge and research agenda of the German Clinical Research Unit. Borderline Personal Disord Emot Dysregul (2014) 1.03
Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord (2009) 1.03
Identifying a network of brain regions involved in aversion-related processing: a cross-species translational investigation. Front Integr Neurosci (2011) 1.00
Pain sensitivity and neural processing during dissociative states in patients with borderline personality disorder with and without comorbid posttraumatic stress disorder: a pilot study. J Psychiatry Neurosci (2010) 1.00
Script-driven imagery of self-injurious behavior in patients with borderline personality disorder: a pilot FMRI study. Acta Psychiatr Scand (2009) 0.92
Alterations in default mode network connectivity during pain processing in borderline personality disorder. Arch Gen Psychiatry (2012) 0.92
COMT val158met polymorphism and neural pain processing. PLoS One (2012) 0.88
Developmental trauma disorder: pros and cons of including formal criteria in the psychiatric diagnostic systems. BMC Psychiatry (2013) 0.86
Morphometric differences in central stress-regulating structures between women with and without borderline personality disorder. J Psychiatry Neurosci (2013) 0.86
ESCAP Expert Article: Borderline personality disorder in adolescence: An expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry (2015) 0.85
The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev Psychobiol (2008) 0.84
Functional connectivity of pain-mediated affect regulation in Borderline Personality Disorder. PLoS One (2012) 0.84
Classical conditioning in borderline personality disorder: an fMRI study. Eur Arch Psychiatry Clin Neurosci (2015) 0.83
State dissociation moderates response to dialectical behavior therapy for posttraumatic stress disorder in women with and without borderline personality disorder. Eur J Psychotraumatol (2016) 0.79
Pain in patients with borderline personality disorder. Personal Ment Health (2014) 0.77
Pain perception in female adolescents with borderline personality disorder. Eur Child Adolesc Psychiatry (2014) 0.77
Trauma-related altered states of consciousness in women with BPD with or without co-occurring PTSD. Eur J Psychotraumatol (2014) 0.76
Deficits in pain perception in borderline personality disorder: results from the thermal grill illusion. Pain (2015) 0.75
Pain Processing after Social Exclusion and Its Relation to Rejection Sensitivity in Borderline Personality Disorder. PLoS One (2015) 0.75
Attention to emotional stimuli in borderline personality disorder - a review of the influence of dissociation, self-reference, and psychotherapeutic interventions. Borderline Personal Disord Emot Dysregul (2016) 0.75
Gene expression profiles in relation to tension and dissociation in borderline personality disorder. PLoS One (2013) 0.75
Dissociation and Alterations in Brain Function and Structure: Implications for Borderline Personality Disorder. Curr Psychiatry Rep (2017) 0.75
Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. Psychopharmacology (Berl) (2008) 0.75
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Dtsch Arztebl Int (2010) 3.67
Hippocampal and amygdalar volumes in dissociative identity disorder. Am J Psychiatry (2006) 3.64
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int (2010) 3.36
Borderline personality disorder. Lancet (2004) 3.32
Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. Am J Psychiatry (2010) 3.17
What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One (2012) 2.44
Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2012) 2.43
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. Ann Intern Med (2012) 2.14
Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychol Med (2005) 1.99
Neural correlates of the classic color and emotional stroop in women with abuse-related posttraumatic stress disorder. Biol Psychiatry (2004) 1.85
Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry (2006) 1.78
Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013. Dtsch Arztebl Int (2015) 1.68
Differentiation of pain ratings in combat-related posttraumatic stress disorder. Pain (2009) 1.60
Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res (2008) 1.59
An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry (2007) 1.50
Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry (2003) 1.48
Self-stigma, empowerment, and perceived legitimacy of discrimination among women with mental illness. Psychiatr Serv (2006) 1.48
Validation of the Spanish version of the Borderline Symptom List, short form (BSL-23). BMC Psychiatry (2013) 1.45
State affective instability in borderline personality disorder assessed by ambulatory monitoring. Psychol Med (2007) 1.45
Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry (2008) 1.40
Self-stigma in women with borderline personality disorder and women with social phobia. J Nerv Ment Dis (2006) 1.39
Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom (2013) 1.38
Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy (2013) 1.32
Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med (2013) 1.31
Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.28
The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology (2008) 1.28
Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun (2005) 1.26
Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood (2010) 1.24
Dialectical behavior therapy for posttraumatic stress disorder related to childhood sexual abuse: a pilot study of an intensive residential treatment program. J Trauma Stress (2011) 1.23
Shame and implicit self-concept in women with borderline personality disorder. Am J Psychiatry (2007) 1.22
Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia (2005) 1.22
Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry (2007) 1.22
Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther (2004) 1.19
Emotional modulation of pain: a clinical perspective. Pain (2006) 1.18
Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev (2010) 1.18
Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combat-related posttraumatic stress disorder. Psychopharmacol Bull (2007) 1.17
Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology (2009) 1.16
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage (2008) 1.16
Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study. J Psychiatr Res (2005) 1.15
Neuronal correlates of cognitive reappraisal in borderline patients with affective instability. Biol Psychiatry (2010) 1.15
Motives for nonsuicidal self-injury among women with borderline personality disorder. J Nerv Ment Dis (2008) 1.14
A valence-dependent group-specific recall bias of retrospective self-reports: a study of borderline personality disorder in everyday life. J Nerv Ment Dis (2006) 1.13
Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep (2007) 1.12
Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs (2005) 1.12
Reliability of three alternate forms of the trail making tests a and B. Arch Clin Neuropsychol (2011) 1.11
Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol (2002) 1.09
Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry (2008) 1.09
Affect regulation and pain in borderline personality disorder: a possible link to the understanding of self-injury. Biol Psychiatry (2010) 1.08
Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci (2007) 1.06
Deep brain stimulation for treatment of refractory depression. Lancet (2005) 1.06
Ecological momentary assessment in borderline personality disorder: a review of recent findings and methodological challenges. J Pers Disord (2012) 1.05
Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry (2007) 1.05
Borderline personality disorder: a dysregulation of the endogenous opioid system? Psychol Rev (2010) 1.04
Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. World J Biol Psychiatry (2009) 1.03
Increased delta power and discrepancies in objective and subjective sleep measurements in borderline personality disorder. J Psychiatr Res (2005) 1.02
The estimated prevalence and correlates of adult ADHD in a German community sample. Eur Arch Psychiatry Clin Neurosci (2011) 1.02
Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry (2010) 1.01
Measuring shame and guilt by self-report questionnaires: a validation study. Psychiatry Res (2007) 1.01
Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology (2011) 1.00
Emotional learning during dissociative states in borderline personality disorder. J Psychiatry Neurosci (2009) 1.00
Psychophysiological ambulatory assessment of affective dysregulation in borderline personality disorder. Psychiatry Res (2007) 1.00
Pain sensitivity and neural processing during dissociative states in patients with borderline personality disorder with and without comorbid posttraumatic stress disorder: a pilot study. J Psychiatry Neurosci (2010) 1.00
Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia (2008) 1.00
Salivary cortisol, heart rate, electrodermal activity and subjective stress responses to the Mannheim Multicomponent Stress Test (MMST). Psychiatry Res (2012) 0.99
Amygdala deactivation as a neural correlate of pain processing in patients with borderline personality disorder and co-occurrent posttraumatic stress disorder. Biol Psychiatry (2008) 0.99
Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder. Ann N Y Acad Sci (2006) 0.98
The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.98
The latest neuroimaging findings in borderline personality disorder. Curr Psychiatry Rep (2010) 0.98
Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci (2014) 0.98
Life context of pharmacological academic performance enhancement among university students--a qualitative approach. BMC Med Ethics (2014) 0.98